Combination Therapies with Anti-CD38 Antibodies and PARP or Adenosine Receptor Inhibitors | Patent Publication Number 20220275090
US 20220275090 A1Publication DateSep 1, 2022
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsDiana Alvarez Arias
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.